Showing 2,660 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6

News
17 April 2014
Access to healthcare

NHS England agrees funding for life-saving hepatitis C drug

Editor's pick
NHS England (press release)
17 April 2014
New & experimental hepatitis C treatment

England: Patients with end-stage liver disease caused by hepatitis C to get new drug

Editor's pick
The Guardian
17 April 2014
New & experimental hepatitis C treatment

BMS combination cures 90% of genotype 1b hepatitis C in 24 weeks

News
17 April 2014
Hepatitis C treatment

Sofosbuvir + ribavirin is safe and effective for people with hepatitis C who have advanced liver disease

News
16 April 2014
Hepatitis B

Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B

News
16 April 2014
New & experimental hepatitis C treatment

AbbVie 3-drug combination cures 92 to 96% of hepatitis C patients with cirrhosis

News
15 April 2014
New & experimental hepatitis C treatment

AbbVie 2-drug combination + ribavirin achieves 100% cure in previously untreated genotype 4 hepatitis C

News
14 April 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir co-formulation cures more than 90% of treatment-naive and retreated genotype 1 patients

News
14 April 2014
New & experimental hepatitis C treatment

Sofosbuvir + simeprevir dual therapy shows high cure rates for hepatitis C patients with or without cirrhosis

News
14 April 2014
Epidemiology

Viral hepatitis more deadly than HIV in Europe

Editor's pick
Science Daily
14 April 2014
Hepatitis C treatment

European liver specialists recommend 'mix-and-match' approach to new hepatitis C drugs

News
11 April 2014
Activism & civil society

International Liver Conference: activists demand affordable hepatitis C treatment

Editor's pick
HepCoalition
11 April 2014
Pharmaceutical industry

U.S. drug industry group defends price of Gilead hepatitis drug

Editor's pick
Reuters
11 April 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir produces early cure for 100% of people with HIV and HCV co-infection

News
11 April 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir is safe and effective for relapsers and hard-to-treat patients

News
11 April 2014
New & experimental hepatitis C treatment

88% of previous relapsers achieve hepatitis C cure with simeprevir-based triple therapy

News
10 April 2014
Hepatitis C treatment

AbbVie interferon-free regimen cures 96% of treatment-experienced genotype 1 hepatitis C infections

News
10 April 2014
New & experimental hepatitis C treatment

Egypt: New Treatments May Defuse Viral Hepatitis Time Bomb

Editor's pick
Inter Press Service
10 April 2014
PrEP science

PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors

News
9 April 2014
Hepatitis C treatment

WHO recommends global use of newest hepatitis C drugs, urges price reductions

News
9 April 2014
Hepatitis C treatment

WHO joins clamour to make new hepatitis C pills affordable

Editor's pick
Reuters
9 April 2014
Hepatitis C treatment

WHO issues its first hepatitis C treatment guidelines

Editor's pick
World Health Organization
9 April 2014
Hepatitis C symptoms & diagnosis

WHO Hepatitis Treatment Guidelines: UNITAID Urges Efforts to Improve Diagnosis as Key to Increase Access to Medicines

Editor's pick
UNITAID
9 April 2014